drug · protein
patient view →efinopegdutide
Phase 2updated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
Phase 2community read0 votes
Protein drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.
targets
Glucagon receptorGlucagon-like peptide 1 receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that